BCL9L and neoplasm: Based on the analysis of our data, BCL9L expression was positively correlated with tumour invasiveness (tumour stage), metastatic ability (lymph node metastasis), cellular pleomorphism (tumour grade) and tumour progression (clinical stage) (Figure S3C).